Vaxcyte (PCVX) Insider Trading & Ownership $32.00 -1.25 (-3.76%) As of 07/7/2025 04:00 PM Eastern Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Vaxcyte (NASDAQ:PCVX) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage3.10%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)6Amount OfInsider Selling(Last 12 Months)$22.73M Get PCVX Insider Trade Alerts Want to know when executives and insiders are buying or selling Vaxcyte stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address PCVX Insider Buying and Selling by Quarter Vaxcyte Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails4/28/2025Gilbert Ray Cisneros, Jr.U.S. Congress Member (D-CA)Buy$32.90$1,001 - $15,0004/15/2025Gilbert Ray Cisneros, Jr.U.S. Congress Member (D-CA)Buy$30.23$1,001 - $15,0004/14/2025Gilbert Ray Cisneros, Jr.U.S. Congress Member (D-CA)Buy$32.04$1,001 - $15,0003/5/2025Jefferson ShreveU.S. Congress Member (R-IN)Sell$73.89$15,001 - $50,0003/3/2025Jim WassilCOOSell8,000$73.27$586,160.00 2/18/2025Andrew GuggenhimeCFOSell8,000$83.85$670,800.00 2/3/2025Jim WassilCOOSell8,000$86.22$689,760.00 1/21/2025Andrew GuggenhimeCFOSell8,000$86.51$692,080.00 1/15/2025Teri LoxamDirectorSell6,250$85.11$531,937.50 1/2/2025Jim WassilCOOSell8,000$83.66$669,280.00 12/18/2024Andrew GuggenhimeCFOSell8,000$88.78$710,240.00 12/9/2024Grant PickeringCEOSell2,366$92.25$218,263.50 12/5/2024Mikhail EydelmanSVPSell5,000$91.49$457,450.00 12/2/2024Grant PickeringCEOSell15,000$92.45$1,386,750.00 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 12/2/2024Jim WassilCOOSell8,000$92.49$739,920.00 11/7/2024Grant PickeringCEOSell2,366$103.89$245,803.74 11/1/2024Grant PickeringCEOSell15,000$106.82$1,602,300.00 11/1/2024Jim WassilCOOSell8,000$106.80$854,400.00 10/18/2024Andrew GuggenhimeCFOSell42,000$115.39$4,846,380.00 10/7/2024Grant PickeringCEOSell7,098$109.21$775,172.58 10/7/2024Mikhail EydelmanSVPSell5,000$109.27$546,350.00 9/18/2024Andrew GuggenhimeCFOSell8,000$115.94$927,520.00 9/3/2024Elvia CowanSVPSell5,000$107.67$538,350.00 9/3/2024Jim WassilCOOSell10,000$111.93$1,119,300.00 8/23/2024Grant PickeringCEOSell15,000$78.98$1,184,700.00 7/23/2024Grant PickeringCEOSell15,000$84.26$1,263,900.00 7/18/2024Andrew GuggenhimeCFOSell8,000$81.17$649,360.00 7/16/2024Elvia CowanSVPSell5,000$85.00$425,000.00 7/8/2024Elvia CowanSVPSell5,000$80.00$400,000.00 (Data available from 1/1/2013 forward) PCVX Insider Trading Activity - Frequently Asked Questions Who is on Vaxcyte's Insider Roster? The list of insiders at Vaxcyte includes Andrew Guggenhime, Elvia Cowan, Grant Pickering, Halley E Gilbert, Heath Lukatch, Jeff Fairman, Jim Wassil, Mikhail Eydelman, Paul Sauer, and Teri Loxam. Learn more on insiders at PCVX. What percentage of Vaxcyte stock is owned by insiders? 3.10% of Vaxcyte stock is owned by insiders. Learn more on PCVX's insider holdings. Which Vaxcyte insiders have been selling company stock? The following insiders have sold PCVX shares in the last 24 months: Andrew Guggenhime ($11,882,220.00), Elvia Cowan ($2,228,456.24), Grant Pickering ($18,077,316.84), Halley E Gilbert ($1,328,600.00), Heath Lukatch ($1,456,380.00), Jim Wassil ($6,189,840.00), Mikhail Eydelman ($3,053,945.41), and Teri Loxam ($531,937.50). How much insider selling is happening at Vaxcyte? Insiders have sold a total of 586,942 Vaxcyte shares in the last 24 months for a total of $44,748,695.99 sold. Which members of congress are trading Vaxcyte? Gilbert Ray Cisneros, Jr. (D-CA) has bought shares of Vaxcyte in the last year totaling $24,000. Jefferson Shreve (R-IN) has sold shares totaling $32,500. Vaxcyte Key ExecutivesMr. Grant E. Pickering M.B.A. (Age 56)Co-Founder, CEO & Director Compensation: $1.13MMr. Andrew L. Guggenhime M.B.A. (Age 56)President & CFO Compensation: $820.81kMr. James Wassil M.B.A. (Age 55)M.S., Executive VP & COO Compensation: $521.05kMr. Mikhail Eydelman J.D. (Age 42)Senior VP, General Counsel, Chief Compliance Officer & Corporate Secretary Compensation: $684.62kDr. Ashish Khanna M.B.A. (Age 52)Ph.D., Co-Founder Dr. Jeff Fairman Ph.D. (Age 60)Co-Founder & VP of Research Ms. Elvia Cowan (Age 51)Senior VP of Finance & Principal Accounting Officer Ms. Janet GraesserSenior Vice President of Corporate Communications & Investor RelationsMs. Whitney JonesChief People OfficerMr. Paul W. Sauer M.B.A. (Age 63)Senior Vice President of Process Development & Manufacturing Compensation: $608.96k More Insider Trading Tools from MarketBeat Related Companies Summit Therapeutics Insider Buying Intra-Cellular Therapies Insider Buying Genmab A/S Insider Buying Moderna Insider Buying Viatris Insider Buying Blueprint Medicines Insider Buying BridgeBio Pharma Insider Buying Verona Pharma PLC American Depositary Share Insider Buying Roivant Sciences Insider Buying Elanco Animal Health Insider Buying Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Micron Insiders Sell But Investors Should Buy, Buy, BuyInsider Selling at NVIDIA Could Turn Into an Opportunity The Top Insider Sells From Q2: Buy, Sell, or Hold?3 Hot Trades for Insiders, But Are They Good Buys for Investors?Insiders Chase Income and Stability in American Tower—Here’s Why This page (NASDAQ:PCVX) was last updated on 7/8/2025 by MarketBeat.com Staff From Our PartnersEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredF1 Engineering Powers This Electric Marine MotorThe future of marine propulsion has arrived - powered by F-1 grade engineering. In collaboration with McLar...The Tomorrow Investor | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredInstant Cash (in 4 clicks)Since 1973, Wall Street has quietly used a strange little pricing quirk to cash flow billions. Now, for the...Awesomely, LLC | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredForget Nvidia, This “Ghost Town” Company Holds the Key to the AI BoomCold War Discovery Could Unlock $100 Trillion in Wealth Jeff recently traveled to an American ghost town to...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Vaxcyte, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Vaxcyte With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.